PHILADELPHIA, May 22, 2017 /PRNewswire/ -- Aberdeen Singapore Fund, Inc. (the "Fund") (NYSE: SGF), a closed-end equity fund, announced today its performance data and portfolio composition as of April 30, 2017.
The Fund's total returns for various periods through April 30, 2017 are provided below. (All figures are based on distributions reinvested at the dividend reinvestment price and are stated net-of-fees):
Cumulative as of 04/30/17 |
Annualized as of 04/30/17 |
|||||||
1 Month |
3 Month |
YTD |
1 Year |
3 Years |
5 Years |
10 Years |
Since Inception |
|
NAV |
1.2 |
7.6 |
17.3 |
14.2 |
-0.5 |
2.8 |
2.2 |
5.0 |
Market Price |
2.4 |
16.7 |
27.7 |
21.8 |
0.3 |
3.2 |
2.4 |
4.3 |
MSCI Singapore |
0.3 |
5.0 |
13.8 |
9.3 |
-1.7 |
1.6 |
3.0 |
6.1 |
On April 30, 2017, the Fund's net assets amounted to US$90.7 million and the Fund's NAV per share was US$12.22.
As of April 30, 2017, the portfolio was invested as follows:
Portfolio Composition |
Percent of |
Financials |
28.9 |
Real Estate |
25.0 |
Industrials |
23.3 |
Telecommunications |
7.0 |
Information Technology |
4.2 |
Health Care |
3.8 |
Consumer Discretionary |
3.7 |
Consumer Staples |
1.9 |
Materials |
0.3 |
Cash |
1.9 |
The Fund's ten largest equity holdings as of April 30, 2017, representing 61.6% of net assets, were:
Stock |
Percent of Net Assets |
Oversea-Chinese Banking Corporation |
10.5 |
DBS Group Holdings |
8.3 |
City Developments |
7.4 |
Singapore Telecom |
7.0 |
United Overseas Bank |
6.6 |
Jardine Matheson |
6.0 |
Keppel Corporation |
4.5 |
Venture Corporation |
3.8 |
Raffles Medical Group |
3.8 |
Comfortdelgro Corp. NPV |
3.7 |
Important Information
Aberdeen Asset Management Inc. has prepared this report based on information sources believed to be accurate and reliable. However, the figures are unaudited and neither the Fund, Aberdeen Asset Management Inc. (the Administrator), Aberdeen Asset Management Asia Limited (the Investment Manager), nor any other person guarantees their accuracy. Investors should seek their own professional advice and should consider the investment objectives, risks, charges and expenses before acting on this information. The Investment Manager and Administrator are each a wholly owned subsidiary of Aberdeen Asset Management PLC. Aberdeen Asset Management PLC announced on March 6, 2017 that it entered into an agreement with Standard Life plc to carry out an all-share merger, subject to regulatory and other approvals. More information about the potential merger can be found on Aberdeen's website at www.aberdeen-asset.com. Aberdeen is a U.S. registered service mark of Aberdeen Asset Management PLC.
Closed-end funds are traded on the secondary market through one of the stock exchanges. The Fund's investment return and principal value will fluctuate so that an investor's shares may be worth more or less than the original cost. Shares of closed-end funds may trade above (a premium) or below (a discount) the net asset value (NAV) of the fund's portfolio. There is no assurance that the Fund will achieve its investment objective.
Total return figures with distributions reinvested at the dividend reinvestment price are stated net-of-fees and represents past performance. Past performance is not indicative of future results, current performance may be higher or lower. Holdings are subject to change and are provided for informational purposes only and should not be deemed as a recommendation to buy or sell the securities shown. Inception date July 31, 1990.
If you wish to receive this information electronically, please contact: [email protected]
SOURCE Aberdeen Singapore Fund, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article